Endocrine Emergencies
Self-paced
1 CEU
Sorry! The enrollment period is currently closed. Please check back soon.
Full course description
This module is part of the Advanced Critical Care Therapeutics Series.
This CE module provides in-depth instruction concerning the pharmacotherapeutic management of endocrine emergencies (diabetic ketoacidosis, hyperosmolar hyperglycemic state, myxedema coma and thyroid storm). Didactic knowledge of the etiology, pathophysiology and drug therapy management on this topic will be provided. Emphasis is placed on designing treatment regimens and identifying monitoring parameters and goals of therapy in this highly specialized practice area. Following completion of this CE topic, participants will have the most up-to-date information concerning the management of endocrine emergencies.
Presented By: Stacey K. Dull, Pharm.D., BCPS
Objectives
- Define diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), myxedema coma, and thyroid storm
- Identify signs and symptoms associated with DKA, HHS, myxedema coma, and thyroid storm
- Design a treatment regimen for a patient with DKA, HHS, myxedema coma, or thyroid storm
Education Credit
Category 1
Creighton University Health Sciences Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.
Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy
Creighton University Health Sciences Continuing Education (HSCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This enduring material, Endocrine Emergencies, is accredited for 1.0 hour(s) for completion of all CE sessions. Term of approval is from this date on August 22, 2020 until August 21, 2023. The Advanced Critical Care Therapeutics is a knowledge-based CE activity.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.